COMMUNIQUÉS West-GlobeNewswire

Bioxodes expands Clinical Advisory Board, shares pivotal trial design for BIOX-101 in intracerebral hemorrhage
17/04/2026
Three world-leading key opinion leaders, researchers and clinicians, join Clinical Advisory Board, reinforcing Bioxodes’ global registrational clinical strategy Positive ongoing discussions with regulators on pivotal [...]
Carbios announces fiscal-year 2025 financial results
17/04/2026
Carbios significantly reduced its operating expenses during 2025, resulting in a €7 million reduction in operating loss Carbios has a solid cash position of €59 million as of December 31, 2025, on a Group basis [...]
CARBIOS présente ses résultats annuels 2025
17/04/2026
Carbios a fortement réduit ses charges opérationnelles au cours de l’année 2025, permettant une réduction de la perte d’exploitation de 7 millions d’euros Carbios dispose d’une trésorerie solide à hauteur de 59 millions [...]
Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock
17/04/2026
NEW HAVEN, Conn., April 16, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the [...]
Kailera Therapeutics Announces Pricing of Initial Public Offering
17/04/2026
WALTHAM, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc. (Nasdaq: KLRA) (Kailera), an advanced clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced [...]
OraSure Technologies Appoints John D. Bertrand to its Board of Directors
17/04/2026
Enters into Cooperation Agreement with Altai Capital Board to Seek Shareholder Approval for Declassification at the 2026 Annual Meeting BETHLEHEM, Pa., April 16, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“ [...]
VapoFil Under Investigation: Evaluating the Vapor Rub Male Enhancement Honey Trick Claims
16/04/2026
A 2026 informational overview of VapoFil ingredients, the viral Vapor Rub male enhancement honey trick trend, supplement label transparency, dosing research context, and what men should know before buying Largo, FL, [...]
Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $463.5 Million
16/04/2026
WALTHAM, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations [...]
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
16/04/2026
WATERTOWN, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases [...]
LifeStance to Host First Quarter 2026 Earnings Conference Call on May 7, 2026
16/04/2026
SCOTTSDALE, Ariz., April 16, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, will issue its first quarter 2026 earnings [...]
Raw Garden 4/20 Deals: Up to 60% Off California Cannabis
17/04/2026
Statewide retailer partnerships unlock limited-time 4/20 deals on single-source cannabis products from April 17–20 SANTA BARBARA, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- Raw Garden ® , California’s leading clean [...]
Allogene Therapeutics Announces Closing of $200.4 Million Public Offering of Common Stock
16/04/2026
SOUTH SAN FRANCISCO, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO) today announced the closing of its previously announced underwritten public offering of 87,500,000 shares of its [...]
OrthoPediatrics Corp. to Report First Quarter Financial Results on April 30, 2026
16/04/2026
WARSAW, Ind., April 16, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced [...]
PacBio to Report First Quarter 2026 Financial Results on May 7, 2026
16/04/2026
MENLO PARK, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its first quarter 2026 financial results on Thursday, May 7, 2026, [...]
JATT II Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering
17/04/2026
WESTFIELD, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- JATT II Acquisition Corp (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the [...]
TerrAscend Appoints Eric Jackson as Chief Financial Officer
16/04/2026
TORONTO, April 16, 2026 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF) , a leading North American cannabis operator, today announced the appointment of Eric Jackson as [...]
New Preclinical Data on STX-1, a First-in-Class Senolytic ADC, To Be Presented at AACR 2026
16/04/2026
PRESS RELEASE New Preclinical Data on STX-1, a First-in-Class Senolytic ADC, To Be Presented at AACR 2026 Presentations highlight therapy-induced senescence as a new therapeutic opportunity and reinforce the potential [...]
Emergent BioSolutions Successfully Refinances Term Loan, Amends Asset-backed Loan Facility and Increases Financial Flexibility
16/04/2026
Refinancing extends maturities, reduces interest expense and positions Emergent for durable, long-term growth as part of its multi-year transformation plan GAITHERSBURG, Md., April 16, 2026 (GLOBE NEWSWIRE) -- Emergent [...]
Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026
16/04/2026
GAITHERSBURG, Md., April 16, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, April 30, 2026, at 5:00 p.m. eastern time to discuss the financial results for the [...]

Pages